Identification of patients at risk

We have developed a ready-to-use CMV tetramer kit, allowing the precise measurement of the number of CMV-specific T cells. This test supports the physician in the monitoring of patients with a high risk of reactivation. Thus tetramers help to identify patients at risk of CMV disease.

The ready-to-use kit is CE certified and provides fast results, in addition to the absolute number of CMV specific T cells the percentage of CD4 and CD8 T cells are also determined.

If you have any questions, please send us a short email. Our specialist will respond promptly.

^{(1) Gratama et al. 2001. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood, 98, 1358-364.}